Target-driven design of a coumarinyl chalcone scaffold based novel EF2 Kinase inhibitor suppresses breast cancer growth in vivo
F. Comert Onder, N. Kahraman, E. Bellur Atici, A. Cagir, H. Kandemir, G. Tatar, T. Taskin Tok, B. Karliga, S. Durdagi, M. Ay, B. Ozpolat
The paper designs a coumarinyl chalcone scaffold-based inhibitor of eEF-2K, showing in vitro and in vivo efficacy against breast cancer.
bioRxiv · Nov 6, 2020Cancer Biology